Page last updated: 2024-10-24

chloroquine and Impetigo

chloroquine has been researched along with Impetigo in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Impetigo: A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WIEDMANN, A1

Other Studies

1 other study available for chloroquine and Impetigo

ArticleYear
[On several old-fashioned treatment methods in dermatology].
    Therapeutische Umschau. Revue therapeutique, 1963, Volume: 20

    Topics: Acridines; Anti-Infective Agents, Local; Arsenicals; Chloroquine; Chlortetracycline; Coal Tar; Derma

1963